NCT07116408View on ClinicalTrials.gov

Intranasal Sphenopalatine Ganglion Blockade for Headaches Following Aneurysmal Subarachnoid Hemorrhage

PHASE4RecruitingINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

May 20, 2024

Primary Completion Date

November 30, 2026

Study Completion Date

May 31, 2027

Conditions

Aneurysmal Subarachnoid Hemorrhage (aSAH)Headache

Interventions

DRUG

Lidocaine (drug)

Tx 360/lidocaine

DEVICE

Tx 360

Tx 360 device

Trial Locations (1)

45409

RECRUITING

Miami Valley Hospital, Dayton

All Listed Sponsors

lead

Wright State University

OTHER